BSNRF Stock UPDATES Biosensors Intl Grp (BSNRF) 0.7500 08/10/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biosensors Intl Grp (BSNRF) 0.7500 $BSNRF

Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2015
PR Newswire - Wed Aug 06, 7:14AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its first fiscal quarter ended 30 June 2014 ("Q1 FY15" .

Russia Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu Jun 12, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rhvvp7/russia) has announced the addition of the "Russia Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Russia Interventional Cardiology Market Outlook to 2020", provides key market data on the Russia Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Russia 4 Overview of Key Companies in Russia, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Boston Scientific Corporation - Abbott Laboratories - Cordis Corporation - Terumo Corporation - Biosensors International Group, Ltd. - St. Jude Medical, Inc. - Biotronik SE & Co. KG - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/rhvvp7/russia

Mexico Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu Jun 12, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8plzfx/mexico) has announced the addition of the "Mexico Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Mexico Interventional Cardiology Market Outlook to 2020", provides key market data on the Mexico Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Mexico 4 Overview of Key Companies in Mexico, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Boston Scientific Corporation - Abbott Laboratories - Terumo Corporation - Asahi Intecc Co., Ltd. - Volcano Corporation - Cordis Corporation - Merit Medical Systems, Inc. - Biosensors International Group, Ltd. - St. Jude Medical, Inc. For more information visit http://www.researchandmarkets.com/research/8plzfx/mexico

South Korea Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Wed Jun 11, 4:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jt69cf/south_korea) has announced the addition of the "South Korea Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "South Korea Interventional Cardiology Market Outlook to 2020", provides key market data on the South Korea Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, South Korea 4 Overview of Key Companies in South Korea, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Terumo Corporation - Abbott Laboratories - Boston Scientific Corporation - Medtronic, Inc. - amg International GmbH - Cordis Corporation - Volcano Corporation - St. Jude Medical, Inc. - Biosensors International Group, Ltd. - Biotronik SE & Co. KG - Asahi Intecc Co., Ltd. For more information visit http://www.researchandmarkets.com/research/jt...outh_korea

Australia Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott , Boston Scientific, Medtronic and Cordis
M2 - Wed Jun 11, 3:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2f7zzz/australia) has announced the addition of the "Australia Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Australia Interventional Cardiology Market Outlook to 2020", provides key market data on the Australia Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Australia 4 Overview of Key Companies in Australia, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Abbott Laboratories - Boston Scientific Corporation - Terumo Corporation - Volcano Corporation - Asahi Intecc Co., Ltd. - Cordis Corporation - St. Jude Medical, Inc. - Biosensors International Group, Ltd. - Biotronik SE & Co. KG For more information visit http://www.researchandmarkets.com/research/2f7zzz/australia

Canada Interventional Cardiology Market Outlook 2014-2020
M2 - Fri Jun 06, 4:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wp4wnb/canada) has announced the addition of the "Canada Interventional Cardiology Market Outlook to 2020" report to their offering. "Canada Interventional Cardiology Market Outlook to 2020", provides key market data on the Canada Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for the market category. - Global corporate-level profiles of key companies operating within the Canada Interventional Cardiology market. Key players covered include: - Boston Scientific Corporation - Abbott Laboratories - Medtronic, Inc. - Cordis Corporation - Terumo Corporation - Volcano Corporation - St. Jude Medical, Inc. - Biosensors International Group, Ltd. - Biotronik SE & Co. KG For more information visit http://www.researchandmarkets.com/research/wp4wnb/canada

EU5 Interventional Cardiology Market Outlook to 2020
M2 - Thu Jun 05, 9:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kg7tl5/eu5) has announced the addition of the "EU5 Interventional Cardiology Market Outlook to 2020" report to their offering. "EU5 Interventional Cardiology Market Outlook to 2020", provides key market data on the EU5 Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Companies Mentioned - Medtronic, Inc. - Abbott Laboratories - Boston Scientific Corporation - Cordis Corporation - Terumo Corporation - Biosensors International Group, Ltd. - Biotronik SE & Co. KG - St. Jude Medical, Inc. - Volcano Corporation - Asahi Intecc Co., Ltd. For more information visit http://www.researchandmarkets.com/research/kg7tl5/eu5

BRIC Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu Jun 05, 5:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lz75kt/bric) has announced the addition of the "BRIC Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "BRIC Interventional Cardiology Market Outlook to 2020", provides key market data on the BRIC Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, BRIC 4 Interventional Cardiology Market, Brazil 5 Interventional Cardiology Market, Russia 6 Interventional Cardiology Market, India 7 Interventional Cardiology Market, China 8 Overview of Key Companies in BRIC Interventional Cardiology Market 9 Interventional Cardiology Market Pipeline Products 10 Appendix Companies Mentioned: - Abbott Laboratories - Asahi Intecc - Biosensors International Group - Biotronik SE & Co - Boston Scientific Corporation - Cordis Corporation - Lepu Medical Technology (Beijing) - Medtronic, Inc. - St. Jude Medical, Inc. - Terumo Corporation - Vascular Concepts Limited - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/lz75kt/bric

Spain Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Fri May 30, 4:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7tx53d/spain) has announced the addition of the "Spain Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Spain Interventional Cardiology Market Outlook to 2020", provides key market data on the Spain Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Spain 4 Overview of Key Companies in Spain, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Abbott Laboratories - Boston Scientific Corporation - Terumo Corporation - Cordis Corporation - Biosensors International Group, Ltd. - Biotronik SE & Co. KG - St. Jude Medical, Inc. - Asahi Intecc Co., Ltd. - Volcano Corporation - Vascular Concepts Limited For more information visit http://www.researchandmarkets.com/research/7tx53d/spain

Biosensors Reports Financial Results for the Third Quarter of Fiscal Year 2014
PR Newswire - Wed Feb 12, 7:01AM CST
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for the third quarter of its Fiscal Year 2014 ("Q3 FY14" and nine months ended 31 December 2013 ("FY14 nine-month period" .

Carlos A. Salup is recognized by Continental Who's Who as a Pinnacle Professional
PR Newswire - Fri Feb 07, 4:41PM CST
/Continental Who's Who/ -- Carlos A. Salup is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine as a result of his role as Gynecologist with Melbourne Internal Medicine Associates.

Associated Announces Dividends
PR Newswire - Tue Jan 28, 3:05PM CST
The Board of Directors of Associated Banc-Corp (NASDAQ:ASBC) today declared a regular quarterly cash dividend of $0.09 per common share, payable on March 17, 2014, to shareholders of record at the close of business on March 3, 2014.

Norway Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Thu Jul 18, 6:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6ctt3d/norway) has announced the addition of the "Norway Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. "Norway Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018", provides key market data on the market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within ten market categories - cardiac rhythm management, interventional cardiology, peripheral vascular devices, prosthetic heart valves, electrophysiology, cardiovascular surgery, external defibrillators, cardiac assist devices, cardiovascular monitoring and diagnostic devices and cardiovascular prosthetic devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Key Topics Covered: 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 What is This Report About? 3 Cardiovascular Devices In Norway 3.1 Overall Revenue 3.2 Company Share 4 Cardiac Assist Devices In Norway 4.1 Overall Revenue 4.2 Overall Volume 4.3 Average Price 4.4 Distribution Share 4.5 Company Share 5 Cardiac Rhythm Management In Norway 5.1 Overall Revenue 5.2 Overall Volume 5.3 Average Price 5.4 Distribution Share 5.5 Company Share 6 Cardiovascular Monitoring and Diagnostic Devices In Norway 6.1 Overall Revenue 6.2 Overall Volume 6.3 Average Price 6.4 Distribution Share 6.5 Norway, Company Share 7 Cardiovascular Prosthetic Devices In Norway 7.1 Overall Revenue 7.2 Overall Volume 7.3 Average Price 7.4 Distribution Share 7.5 Company Share 8 Cardiovascular Surgery In Norway 8.1 Overall Revenue 8.2 Overall Volume 8.3 Average Price 8.4 Distribution Share 8.5 Company Share 9 Electrophysiology In Norway 9.1 Overall Revenue 9.2 Overall Volume 9.4 Distribution Share 9.5 Company Share 10 External Defibrillators In Norway 10.1 Overall Revenue 10.2 Overall Volume 10.3 Average Price 10.4 Distribution Share 10.5 Company Share 11 Interventional Cardiology In Norway 11.1 Overall Revenue 11.2 Overall Volume 11.3 Average Price 11.4 Distribution Share 11.5 Company Share 12 Peripheral Vascular Devices In Norway 12.1 Overall Revenue 12.2 Overall Volume 12.3 Average Price 12.4 Distribution Share 12.5 Company Share 13 Prosthetic Heart Valves In Norway 13.1 Overall Revenue 13.2 Overall Volume 13.3 Average Price 13.4 Distribution Share 13.5 Company Share 14 Overview of Key Companies in Norway Cardiovascular Devices Market 15 Appendix Companies Mentioned - AGA Medical Holdings, Inc - Abbott Laboratories - B. Braun Melsungen AG - Berlin Heart GmbH - Biosense Webster, Inc. - Biosensors International Group - Biotronik SE & Co. KG - Boston Scientific Corporation - C. R. Bard, Inc. - Cardiac Science Corporation - CareFusion Corporation - Cordis Corporation - Covidien plc - Edwards Lifesciences Corporation - Fukuda Denshi Co., Ltd. - GE Healthcare - HeartWare International, Inc - MAQUET GmbH & Co. KG - Medtronic, Inc. - Nihon Kohden Corporation - OSI Systems, Inc. - Opto Circuits India Limited - Philips - Schiller AG - Sorin S.p.A. - St. Jude Medical, Inc. - Teleflex Incorporated - Terumo Corporation - Thoratec Corporation - Volcano Corporation - W. L. Gore & Associates, Inc. - Welch Allyn Inc - Zoll Medical Corporation - ev3 Inc For more information visit http://www.researchandmarkets.com/research/6ctt3d/norway

Global Medical Devices Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies
M2 - Wed Jul 17, 5:15AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3lxnzj/global_medical) has announced the addition of iCD Research's new report "Global Medical Devices Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies" to their offering. Executives from the global medical device industry anticipate an increase in consolidation, with 55% of respondents projecting an increase in merger and acquisition (MandA) activities in 2013. This report analyzes how the media spend, marketing and sales strategies and practices, and business planning of the medical devices industry supplier companies are set to change in 2013-2014. Additionally, this report presents comparative analysis between four years of survey results (wherever applicable). This report provides the current size of the marketing and advertising budgets of global medical devices industry suppliers and how their spending will change, providing an insight into global marketing behaviour. In addition, the report identifies future gro

Boston Scientific Corporation Market Share Analysis Report
M2 - Mon Jun 10, 8:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hjv25g/boston_scientific) has announced the addition of the "Boston Scientific Corporation Market Share Analysis" company profile to their offering. This report, Boston Scientific Corporation Market Share Analysis provides in-depth information on Boston Scientific Corporation's market position in the different medical equipment markets it operates in. The report provides Boston Scientific Corporation market share information in six key market categories - Remote Patient Monitoring - Neurostimulation Devices - Cardiac Rhythm Management - Electrophysiology - Interventional Cardiology - Peripheral Vascular Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - Global company shares (in Revenues) information for the key markets Boston Scientific Corporation operates in - Patient Monitoring, Neurology Devices and Cardiovascular Devices - Boston Scientific Corporation's company shares (in Revenues) information for all the key countries the company has presence in - Canada, China, Brazil, United States, Spain, Japan, Italy, Australia, Germany, United Kingdom, India and France. - Boston Scientific Corporation's company shares (in Revenues) information for all the key market categories the company has presence in - Remote Patient Monitoring, Neurostimulation Devices, Cardiac Rhythm Management, Electrophysiology, Interventional Cardiology and Peripheral Vascular Devices. - All the key data-points are for 2011 and cover all the key regions - North America, Europe, Asia Pacific (APAC), South and Central America and Middle East and Africa. - Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries. - The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value proposition and the business climate it operates in. - Comprehensive coverage of the latest financial deals involving the company and its subsidiaries. Companies Mentioned - Biotronik SE & Co. KG - Medtronic, Inc. - St. Jude Medical, Inc. - Honeywell HomMed LLC - Philips Healthcare - GE Healthcare - Cardiocom, LLC - Robert Bosch Healthcare Systems, Inc. - Schiller AG - Nihon Kohden Corporation - Numera - Cyberonics, Inc. - Sorin S.p.A. - Taisho Biomed Instruments Co., Ltd. - Shree Pacetronix Ltd. - Biosense Webster, Inc. - C. R. Bard, Inc. - Japan Lifeline Co., Ltd. - Abbott Laboratories - Terumo Corporation - Cordis Corporation - Volcano Corporation - Lepu Medical Technology (Beijing) Co., Ltd. - Biosensors International Group, Ltd. - Asahi Intecc Co., Ltd. - MicroPort Scientific Corporation - Goodman Co., Ltd. - Eurocor GmbH - Vascular Concepts Limited - Sahajanand Medical Technologies Pvt. Ltd. - HEXACATH - AlviMedica Medical Technologies Inc. - Shanghai MicroPort Medical (Group) Co.,Ltd. - amg International GmbH - OptiMed Medizinische Instrumente GmbH - B. Braun Melsungen AG - Covidien plc - AngioDynamics, Inc. - Cook Medical Incorporated - W. L. Gore & Associates, Inc. - Bolton Medical, Inc. - Merit Medical Systems, Inc. For more information visit http://www.researchandmarkets.com/research/hj...scientific About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Biosensors Completes Spectrum Dynamics Assets Acquisition
PR Newswire - Sun May 26, 7:02AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced the completion of its acquisition of substantially all assets of Spectrum Dynamics, a leader in advanced functional assessment technologies, including those used to evaluate patients for cardiac interventions.

Biosensors to Acquire Assets of Spectrum Dynamics
PR Newswire - Thu May 16, 6:41AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, announced on May 13, 2013 that it has entered into an agreement to acquire substantially all assets of Spectrum Dynamics, a leader in advanced functional assessment technologies, including those used to evaluate patients for cardiac interventions, subject to the fulfillment of certain conditions.

Biosensors Collaborates with Terumo to Promote Nobori(TM) in Japan
PR Newswire - Thu Feb 07, 9:04AM CST
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, has announced a collaboration with Terumo Corporation to promote the Nobori(TM) drug-eluting stent (DES) system at specific specialist cardiology centers in Japan.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lecanemab Shines in 5-Year Alzheimer's Study at CTAD

Updated Category News Views 117

Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...

Continue Reading
Lilly Endowment Boosts Military Families with $10M Grant

Updated Category News Views 36

A Game-Changer for Semper Fi & America's Fund Dive in, folks. What we've got here is a hefty chunk of change — $10 million to be precise — dropped into Semper Fi & America's Fund's lap by Lilly Endowment Inc. We're talking about a grant designed to shore up the long-term support system crafted for the brave souls in military families. It’s about time a significant...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 39

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 79

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 48

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
Horizon Capital Hits €200M for Ukraine Resilience

Updated Category News Views 87

An Unprecedented Leap Amidst Uncertainty Right in the middle of rebuilding a nation, Horizon Capital's Catalyst Fund has managed to tap into a well of optimism—or guts, depending on how you look at it. With €200 million already in its pocket out of a €300 million goal, this private equity powerhouse is taking a calculated gamble on Ukraine's economic resilience and...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 78

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 35

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 148

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
Parallels Desktop Tops 2026 Picks for Windows on Mac

Updated Category News Views 84

Diving into the Cross-Platform Conundrum Now, I've been in the trenches long enough to know that when companies start relying on Mac computers but can't ditch their essential Windows apps, they're bound to hit a digital brick wall. Picture this—accounting, enterprise management, all that jazz that still needs Windows to function. For those jumping between these two...

Continue Reading

Top 5 Most Recently Viewed Articles

Xtract One Technologies Partners with Manor ISD for Enhanced Security

Updated Category News Views 273

Xtract One Technologies Partners with Manor ISD for Enhanced Security Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) has recently entered into an agreement with Manor Independent School District (ISD) to solidify their security measures within the district. This collaboration aims to implement advanced security solutions designed to protect students, staff,...

Continue Reading
Bill Gates Explains His Views on Crypto and Investment Choices

Updated Category News Views 313

Bill Gates' Perspective on Cryptocurrencies Bill Gates, known for founding Microsoft, has shared his skepticism regarding cryptocurrencies, especially Bitcoin. His remarks often point to his belief that cryptocurrencies lack intrinsic value compared to other investments that produce tangible results. The Value of Tangible Investments In discussions, Gates has been clear...

Continue Reading
An In-Depth Look at Broadcom's Industry Standing and Competition

Updated Category News Views 267

Understanding Broadcom's Market Position In today's rapidly evolving business landscape, understanding the market dynamics within the semiconductor industry is crucial for investors and analysts alike. Broadcom (NASDAQ: AVGO) stands as a key player in this competitive arena. This article takes a closer look at Broadcom's market position against its competitors in the...

Continue Reading
European Central Bank Faces Challenges Amid Weak Growth Signs

Updated Category News Views 115

Indicators of Economic Strain in the Euro Zone After a series of interest rate cuts this year, the Eurozone faces significant economic challenges. Policymakers have expressed their concerns regarding persistently weak growth, exacerbated by potential U.S. trade tariffs. As inflation appears to be under control, the looming question is how these tariffs could adversely...

Continue Reading
5 Unopposed Tips for Donor Management Like a Pro

Updated Category Business Views 348

Essential Donor Management Tips for Non-Profit Success Being a non-profit organization manager can be challenging. If you are not dealing with funding and financial sustainability, you are likely to deal with donor retention and engagement. You are also likely to deal with attracting and retaining staff and volunteers. Your organization's reputation can also be put to the...

Continue Reading